• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期胰腺癌的症状对能量摄入很重要。

Symptoms in advanced pancreatic cancer are of importance for energy intake.

机构信息

Regional Centre for Excellence in Palliative Care, Oslo University Hospital, Oslo, Norway.

出版信息

Support Care Cancer. 2013 Jan;21(1):219-27. doi: 10.1007/s00520-012-1514-8. Epub 2012 Jun 10.

DOI:10.1007/s00520-012-1514-8
PMID:22684989
Abstract

PURPOSE

Cancer cachexia and low energy intake (EI) probably contribute to weight loss in advanced pancreatic cancer (PC). However, little is known about the actual EI in this disease. Aims were to assess EI, weight loss and symptoms during the disease course and investigate associations between symptoms and EI.

METHODS

Thirty-nine patients (21 males) with advanced PC were consecutively included and followed every 4 weeks until the end of life. A 24-h dietary recall was used to assess EI. The Edmonton Symptom Assessment System (ESAS) and the PC-specific health-related quality of life questionnaire (QLQ-PAN26) were used for symptom assessment.

RESULTS

Median age was 62 years (48-88), WHO performance status 1 (0-2) and survival 5 months (1-25). Seventeen (44 %) patients had unresectable cancer, 16 (41 %) metastatic and six (15 %) recurrent disease. Upon inclusion, 37 (95 %) reported weight loss (median 4.0 kg per month). During follow-up, median weight loss per month was <1.0 kg. Forty to 65 % had EI <29 kcal/kg/day (cut-off value for weight maintenance) during the observation period but they did not lose more weight than patients with EI  ≥  29 kcal. Strong negative correlations (r range) were found between EI and pain (0.51-0.61), fatigue (0.54-0.67), oral dryness (0.61-0.64) and loss of appetite (0.53-0.71).

CONCLUSION

In this study, several symptoms influenced EI negatively. Low EI did not completely explain weight loss in this patient group, but careful monitoring and early follow-up of symptoms may be important interventions to reduce weight loss in advanced PC.

摘要

目的

癌症恶病质和低能量摄入(EI)可能导致晚期胰腺癌(PC)的体重下降。然而,对于这种疾病的实际 EI 知之甚少。本研究旨在评估疾病过程中的 EI、体重减轻和症状,并探讨症状与 EI 之间的关系。

方法

连续纳入 39 例(21 例男性)晚期 PC 患者,每 4 周随访一次,直至死亡。使用 24 小时膳食回顾法评估 EI。采用埃德蒙顿症状评估系统(ESAS)和 PC 特异性健康相关生活质量问卷(QLQ-PAN26)评估症状。

结果

中位年龄为 62 岁(48-88 岁),WHO 体能状态为 1 级(0-2 级),生存时间为 5 个月(1-25 个月)。17 例(44%)患者为不可切除性肿瘤,16 例(41%)为转移性肿瘤,6 例(15%)为复发性肿瘤。纳入时,37 例(95%)患者报告体重减轻(每月平均 4.0kg)。随访期间,每月体重减轻中位数<1.0kg。40%-65%的患者在观察期间的 EI<29kcal/kg/天(维持体重的临界值),但他们的体重减轻并不比 EI≥29kcal/kg/天的患者多。EI 与疼痛(r 范围为 0.51-0.61)、疲劳(0.54-0.67)、口干(0.61-0.64)和食欲下降(0.53-0.71)呈强负相关。

结论

在这项研究中,一些症状对 EI 产生负面影响。低 EI 并不能完全解释该患者组的体重减轻,但仔细监测和早期随访症状可能是减少晚期 PC 体重减轻的重要干预措施。

相似文献

1
Symptoms in advanced pancreatic cancer are of importance for energy intake.晚期胰腺癌的症状对能量摄入很重要。
Support Care Cancer. 2013 Jan;21(1):219-27. doi: 10.1007/s00520-012-1514-8. Epub 2012 Jun 10.
2
Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study.晚期胰腺癌的症状特征与姑息治疗:一项前瞻性研究。
Support Care Cancer. 2006 Nov;14(11):1126-33. doi: 10.1007/s00520-006-0067-0. Epub 2006 Apr 7.
3
Dietary energy density is associated with energy intake in palliative care cancer patients.膳食能量密度与姑息治疗癌症患者的能量摄入有关。
Support Care Cancer. 2012 Nov;20(11):2851-7. doi: 10.1007/s00520-012-1410-2. Epub 2012 Feb 19.
4
Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? - analysis from a multicenter cross sectional study.癌症恶病质癌症患者的体重减轻、食欲减退和食物摄入量:三者密切相关?——一项多中心横断面研究的分析
Acta Oncol. 2014 Apr;53(4):539-46. doi: 10.3109/0284186X.2013.823239. Epub 2013 Sep 2.
5
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.癌症恶病质的定义:体重减轻、食物摄入量减少以及全身炎症对功能状态和预后的影响。
Am J Clin Nutr. 2006 Jun;83(6):1345-50. doi: 10.1093/ajcn/83.6.1345.
6
Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients.验证《头颈部患者症状清单》作为头颈部癌症患者营养影响症状评估工具的有效性。
Support Care Cancer. 2013 Jan;21(1):27-34. doi: 10.1007/s00520-012-1483-y. Epub 2012 May 16.
7
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.富含鱼油的口服营养补充剂对胰腺癌患者体重减轻的影响。
Br J Cancer. 1999 Sep;81(1):80-6. doi: 10.1038/sj.bjc.6690654.
8
Validity of 24-h recalls in (pre-)school aged children: comparison of proxy-reported energy intakes with measured energy expenditure.学龄前儿童24小时回顾法的有效性:代理报告的能量摄入量与测量的能量消耗的比较。
Clin Nutr. 2014 Feb;33(1):79-84. doi: 10.1016/j.clnu.2013.03.018. Epub 2013 Apr 6.
9
Health-related quality of life across cancer cachexia stages.癌症恶病质各阶段的健康相关生活质量。
Ann Palliat Med. 2019 Jan;8(1):33-42. doi: 10.21037/apm.2018.08.04. Epub 2018 Sep 5.
10
Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer.体重减轻与胰腺癌患者的高瘦素血症无关。
J Clin Endocrinol Metab. 2001 Jan;86(1):162-6. doi: 10.1210/jcem.86.1.7104.

引用本文的文献

1
Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study.胰腺晚期腺癌的胰酶替代疗法可改善总生存期:一项回顾性单机构研究。
Oncologist. 2025 Apr 4;30(4). doi: 10.1093/oncolo/oyaf014.
2
Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle.肠道微生物群与癌症免疫治疗反应的营养相关预测因素:解开谜团
BJC Rep. 2023 Aug 2;1(1):5. doi: 10.1038/s44276-023-00008-8.
3
The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer.

本文引用的文献

1
The influence of chemotherapy on taste perception and food hedonics: a systematic review.化疗对味觉感知和食物愉悦感的影响:系统评价。
Cancer Treat Rev. 2012 Apr;38(2):152-63. doi: 10.1016/j.ctrv.2011.04.008. Epub 2011 May 25.
2
Definition and classification of cancer cachexia: an international consensus.癌症恶病质的定义和分类:国际共识。
Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
3
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer.
肌肉减少性肥胖在预测胃肠道癌症患者预后中的作用。
Cancer Med. 2024 Jul;13(13):e7452. doi: 10.1002/cam4.7452.
4
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 Investigation.基于炎症参数的恶病质相关生存情况与胰腺癌及其他胃肠道肿瘤患者复杂传统营养评估的比较——CONKO 020研究
Cancers (Basel). 2024 Mar 18;16(6):1194. doi: 10.3390/cancers16061194.
5
Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial.通过远程观察和营养指导提供支持(STRONG),一项旨在减少胰腺癌患者营养不良的数字健康干预措施:一项试点随机对照试验的研究方案。
Contemp Clin Trials Commun. 2024 Feb 23;38:101271. doi: 10.1016/j.conctc.2024.101271. eCollection 2024 Apr.
6
Selected parameters of nutritional status in patients with pancreatic head cancer - own experience.胰头癌患者营养状况的选定参数——自身经验
Prz Gastroenterol. 2023;18(3):308-312. doi: 10.5114/pg.2023.131392. Epub 2023 Sep 22.
7
Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer.尽管疾病得到控制,但仍出现肌肉和脂肪消耗:胰腺癌姑息化疗未得到解决的副作用
Cancers (Basel). 2023 Sep 1;15(17):4368. doi: 10.3390/cancers15174368.
8
Cancer cachexia: Pathophysiology and association with cancer-related pain.癌症恶病质:病理生理学及其与癌痛的关联
Front Pain Res (Lausanne). 2022 Aug 22;3:971295. doi: 10.3389/fpain.2022.971295. eCollection 2022.
9
Clinical and economic value of oral nutrition supplements in patients with cancer: a position paper from the Survivorship Care and Nutritional Support Working Group of Alliance Against Cancer.癌症患者口服营养补充的临床和经济价值:抗癌联盟生存护理和营养支持工作组的立场文件。
Support Care Cancer. 2022 Nov;30(11):9667-9679. doi: 10.1007/s00520-022-07269-y. Epub 2022 Jul 6.
10
Exercise-Based Interventions to Counteract Skeletal Muscle Mass Loss in People with Cancer: Can We Overcome the Odds?基于运动的干预措施对癌症患者骨骼肌质量丢失的影响:我们能否克服困难?
Sports Med. 2022 May;52(5):1009-1027. doi: 10.1007/s40279-021-01638-z. Epub 2022 Feb 4.
癌症恶病质:与癌症相关的非自愿性体重减轻有关的项目和领域的系统文献综述。
Crit Rev Oncol Hematol. 2011 Oct;80(1):114-44. doi: 10.1016/j.critrevonc.2010.10.004. Epub 2011 Jan 8.
4
Nutritional status of patients with locally advanced pancreatic cancer: a pilot study.局部晚期胰腺癌患者的营养状况:一项初步研究。
Support Care Cancer. 2011 Nov;19(11):1729-34. doi: 10.1007/s00520-010-1011-x. Epub 2010 Oct 22.
5
Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy.味觉障碍对化疗癌症患者饮食行为的影响。
Nutr J. 2010 Mar 24;9:15. doi: 10.1186/1475-2891-9-15.
6
A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System.用于定义埃德蒙顿症状评估系统中度和重度症状的单一数值切点。
J Pain Symptom Manage. 2010 Feb;39(2):241-9. doi: 10.1016/j.jpainsymman.2009.06.010. Epub 2009 Dec 5.
7
Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia.厌食恶病质综合征的组成部分:癌症相关性厌食的胃肠道症状相关性。
Support Care Cancer. 2009 Dec;17(12):1531-41. doi: 10.1007/s00520-009-0623-5. Epub 2009 Apr 7.
8
Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status.晚期癌症患者的上消化道症状:与营养和功能状态的关系。
Support Care Cancer. 2009 Oct;17(10):1317-24. doi: 10.1007/s00520-009-0590-x. Epub 2009 Feb 8.
9
Pancreatic enzyme supplementation in pancreatic cancer.胰腺癌中的胰酶补充治疗
J Support Oncol. 2008 Nov-Dec;6(8):393-6.
10
Cachexia: a new definition.恶病质:一个新定义。
Clin Nutr. 2008 Dec;27(6):793-9. doi: 10.1016/j.clnu.2008.06.013. Epub 2008 Aug 21.